Neurological side-effects of linezolid manifesting as a posterior reversible leuco-encephalopathy syndrome (PRES) is rare. Early identification of this offending drug might reverse this catastrophic event. We report a 45-year-old female, who was diagnosed as a case of disseminated tuberculosis and was treated with antitubercular drugs (ATT), but later developed ATT-induced hepatitis. She was then put on modified ATT (moxifloxacin, terizidone, and linezolid). In the next two days she developed an altered sensorium. Brain imaging was suggestive of PRES. Linezolid was withdrawn, following which she showed an excellent clinical and radiological recovery.
ThaiXCBruno-MurthaLA. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events. Pharmacotherapy2006; 26: 183–189.
4.
ShnekerBFBaylinPDNakhlaME. Linezolid inducing complex partial status epilepticus in a patient with epilepsy. Neurology2009; 72: 378–379.
5.
HincheyJChavesCAppignaniB, et al.A reversible posterior leukoencephalopathy syndrome. N Engl J Med.1996; 334: 494–500.
6.
GilbertBWGabrielAVelazquezL. A case of antibiotic-induced posterior reversible encephalopathy syndrome. Hosp Pharm2020; 55: 338–341.
7.
Bitar De Zayas-EnriquezASoperC. Daptomycin-Induced posterior reversible encephalopathy syndrome (PRES). Case Rep Neurol Med2019; 2019: 8756932.
8.
El-SheikhSMemonMMujtabaA, et al.An uncommon cause of posterior reversible encephalopathy syndrome related to antibiotic ingestion. Cureus2018; 10: 3540.
RussellMEIvanhoeCBVerduzco-GutierrezM. Rehabilitation of a 46-year-old woman with subarachnoid hemorrhage complicated by linezolid-induced posterior reversible encephalopathy syndrome (pres): a case report. P M and R - The Journal of Injury, Function and Rehabilitation4: S378. No. 10, Oct 2012 – USA.
11.
RupprechtTAPfisterHW. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol.2005; 12: 536–542.
12.
De VrieseASCosterRVSmetJ, et al.Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis.2006; 42: 1111–1117.
13.
Almoussa M, Goertzen A, Brauckmann S, et al. Posterior reversible encephalopathy syndrome due to hypomagnesemia: a case report and literature review. Case Rep Med. 2018; 29: 1–6.
